Top Biopharma Companies Increase Medical Engagement with Veeva Link Scientific Awareness
Three of the top ten biopharmaceutical firms are now using Veeva Systems’ recently introduced Veeva Link Scientific Knowledge to learn about consumer awareness of and sentiment toward their products, according to the company’s announcement today. In order to help medical teams enhance their product strategy and effectively inform the scientific and medical community about various therapies, Veeva Link Scientific Awareness provides critical success metrics across scientific, digital, and social channels.
“Medical teams are moving from volume-based activity metrics to value-driven standards that show the external impact of medical activities among the scientific and clinical community”, “Veeva Link Scientific Awareness helps us quickly assess product awareness across channels to drive engagements that strengthen relationships and better serve patients.
Zijian Zhao, Global Head of Portfolio Strategy, Novartis
The Veeva Link product line, a contemporary data platform that blends intelligent software automation with human curation to ensure accuracy and depth, includes Veeva Link Scientific Awareness. Veeva Link can now deliver real-time information in an increasing variety of fields, such as sales, medicine, marketing, and clinical. The application, which is accessible in 87 countries, analyses information from more than 300,000 medical conferences and 100 million social publications. These events were organised by more than 1,000 specialists and were approved by more than 100 doctors.
“Real-time insights are critical to understanding the evolving healthcare ecosystem and tailoring engagements with scientific experts to meet their specific needs across all therapeutic areas”, “Veeva Link Scientific Awareness helps medical teams guide more effective communications that deepen product understanding so patients and physicians are better informed in today’s digital and on-demand world.”
Kilian Weiss, CEO of Veeva Link
